Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03755791 |
|---|---|
| Brief Title: | Study of Cabozantinib in Combination With Atezolizumab Versus Sorafenib in Subjects With Advanced HCC Who Have Not Received Previous Systemic Anticancer Therapy (COSMIC-312) |
| First Submitted : | November 26, 2018 |
| First Submitted that Met QC Criteria : | November 26, 2018 |
| First Posted : | November 28, 2018 |
| Certification/Extension First Submitted : | March 8, 2022 |
| Certification/Extension First Submitted that Met QC Criteria : | March 14, 2022 |
| Certification/Extension First Posted : | March 16, 2022 |
| Last Update Submitted that Met QC Criteria : | March 20, 2024 |
| Last Update Posted : | March 22, 2024 |